» Articles » PMID: 25948317

A Flow Cytometric Approach to Quantify Biofilms

Overview
Publisher Springer
Specialty Microbiology
Date 2015 May 8
PMID 25948317
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Since biofilms are important in many clinical, industrial, and environmental settings, reliable methods to quantify these sessile microbial populations are crucial. Most of the currently available techniques do not allow the enumeration of the viable cell fraction within the biofilm and are often time consuming. This paper proposes flow cytometry (FCM) using the single-stain viability dye TO-PRO(®)-3 iodide as a fast and precise alternative. Mature biofilms of Candida albicans and Escherichia coli were used to optimize biofilm removal and dissociation, as a single-cell suspension is needed for accurate FCM enumeration. To assess the feasibility of FCM quantification of biofilms, E. coli and C. albicans biofilms were analyzed using FCM and crystal violet staining at different time points. A combination of scraping and rinsing proved to be the most efficient technique for biofilm removal. Sonicating for 10 min eliminated the remaining aggregates, resulting in a single-cell suspension. Repeated FCM measurements of biofilm samples revealed a good intraday precision of approximately 5 %. FCM quantification and the crystal violet assay yielded similar biofilm growth curves for both microorganisms, confirming the applicability of our technique. These results show that FCM using TO-PRO(®)-3 iodide as a single-stain viability dye is a valid fast alternative for the quantification of viable cells in a biofilm.

Citing Articles

Opportunities in optical and electrical single-cell technologies to study microbial ecosystems.

Mermans F, Mattelin V, Van den Eeckhoudt R, Garcia-Timermans C, Van Landuyt J, Guo Y Front Microbiol. 2023; 14:1233705.

PMID: 37692384 PMC: 10486927. DOI: 10.3389/fmicb.2023.1233705.


Biofilm-Forming Ability of and Considering Physicochemical and Topographical Surface Properties.

Zand E, Pfanner H, Domig K, Sinn G, Zunabovic-Pichler M, Jaeger H Foods. 2021; 10(3).

PMID: 33805651 PMC: 8001712. DOI: 10.3390/foods10030611.


Pathogens electrogenicity as a tool for in-situ metabolic activity monitoring and drug assessment in biofilms.

Miran W, Naradasu D, Okamoto A iScience. 2021; 24(2):102068.

PMID: 33554070 PMC: 7859304. DOI: 10.1016/j.isci.2021.102068.


Pitfalls Associated with Discriminating Mixed-Species Biofilms by Flow Cytometry.

Grainha T, Magalhaes A, Melo L, Pereira M Antibiotics (Basel). 2020; 9(11).

PMID: 33121057 PMC: 7694060. DOI: 10.3390/antibiotics9110741.


Nanovectorized Microalgal Extracts to Fight and Biofilms: Impact of Dual-Species Conditions.

Lemoine V, Bernard C, Leman-Loubiere C, Clement-Larosiere B, Girardot M, Boudesocque-Delaye L Antibiotics (Basel). 2020; 9(6).

PMID: 32466354 PMC: 7344943. DOI: 10.3390/antibiotics9060279.


References
1.
Harriott M, Noverr M . Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrob Agents Chemother. 2010; 54(9):3746-55. PMC: 2934986. DOI: 10.1128/AAC.00573-10. View

2.
Suzuki N, Yoshida A, Nakano Y . Quantitative analysis of multi-species oral biofilms by TaqMan Real-Time PCR. Clin Med Res. 2005; 3(3):176-85. PMC: 1237159. DOI: 10.3121/cmr.3.3.176. View

3.
Cos P, Tote K, Horemans T, Maes L . Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des. 2010; 16(20):2279-95. DOI: 10.2174/138161210791792868. View

4.
Cerca F, Andrade F, Franca A, Bonifacio Andrade E, Ribeiro A, Almeida A . Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J Med Microbiol. 2011; 60(Pt 12):1717-1724. PMC: 10727147. DOI: 10.1099/jmm.0.031922-0. View

5.
Nickzad A, Deziel E . The involvement of rhamnolipids in microbial cell adhesion and biofilm development - an approach for control?. Lett Appl Microbiol. 2013; 58(5):447-53. DOI: 10.1111/lam.12211. View